Activated carbon ‘acts like a slow-release drug capsule’ in drug delivery study
Researchers at the University of Illinois at Chicago reported that combining activated charcoal with herpes treatment acyclovir, improves the drug’s efficacy.
Archives for August 19, 2019
Roche’s tumour-agnostic drug approved by FDA, priced under competitor drug
Roche receives US FDA approval with two indications for Rozlytrek, prices the drug at almost half of Bayer’s similar drug.
Risk management platform addresses pharma’s cybersecurity challenges
Intraprise Health creates the BluePrint Protect platform designed to solve cybersecurity challenges across the pharmaceutical supply chain as third-party data sharing accelerates.
Veeva launches AI app that automates case intake
Veeva Systems launches a software application aiming to reduce the time and effort of manual data entry, which will be integrated to its cloud-based suite.
Ex vivo 3D cell culture tech makes ‘true drug response prediction’ possible: Kiyatec
Capital Health joins Kiyatec’s clinical trial to validate a patient-specific predictor test to improve response to cancer therapies for glioblastoma and anaplastic astrocytoma.
PCRF taps Datavant to de-identify and link patient data
PCRF has selected Datavant to de-identify and link patient data across its clinical research network, which will ‘empower’ medical researchers while protecting patient privacy.
Frontage expands site to accommodate nicotine-related studies, develops assay portfolio
Frontage Clinical Services has expanded its site in New Jersey to accommodate nicotine-related studies and is developing a portfolio of assays to evaluate tobacco-specific biomarkers.
ClinOne puts the spotlight on communication during trials
ClinOne adds ‘media package’ to its offering to standardize communication between researchers and participants in clinical trials.